These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7866806

  • 1. Effect of sulglycotide in the prevention of duodenal ulcer relapse.
    De Conca V, Saccomanno S, Dodero M, Aste H.
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):25-8. PubMed ID: 7866806
    [Abstract] [Full Text] [Related]

  • 2. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study].
    Ciaco A, Papi C, Capurso L.
    Minerva Gastroenterol Dietol; 1992 Jan; 38(3):153-9. PubMed ID: 1363719
    [Abstract] [Full Text] [Related]

  • 3. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
    Ocaña Andrade E, Porras Katz JC, Beltrán Escobar G, Jáuregui Garduño JL.
    Rev Gastroenterol Mex; 1997 Jan; 62(2):94-7. PubMed ID: 9471669
    [Abstract] [Full Text] [Related]

  • 4. Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison.
    Becker U, Faurschou P, Jensen J, Lindorff K, Pedersen PB, Ranløv PJ.
    Scand J Gastroenterol; 1984 May; 19(3):405-10. PubMed ID: 6377466
    [Abstract] [Full Text] [Related]

  • 5. Prevention of duodenal ulcer relapse by cimetidine: a one-year double-blind trial.
    Hetzel DJ, Shearman DJ, Hecker R, Sheers R.
    Med J Aust; 1979 Jun 02; 1(11):529-31. PubMed ID: 381873
    [Abstract] [Full Text] [Related]

  • 6. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G, Montrone F, Petrillo M, Caruso I, Ardizzone S.
    Scand J Gastroenterol; 1993 Oct 02; 28(10):875-8. PubMed ID: 8266016
    [Abstract] [Full Text] [Related]

  • 7. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study.
    Classen M, Bethge H, Brunner G, Dirr B, Frotz H, Gabor M, Gail H, Grabner R, Hagenmüller F, Heinkel K.
    Scand J Gastroenterol Suppl; 1983 Oct 02; 83():61-8. PubMed ID: 6356323
    [Abstract] [Full Text] [Related]

  • 8. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M, Bianchi Porro G.
    Hepatogastroenterology; 1980 Oct 02; 27(5):369-71. PubMed ID: 7009360
    [Abstract] [Full Text] [Related]

  • 9. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
    Bytzer P, Teglbjaerg PS, Danish Ulcer Study Group.
    Am J Gastroenterol; 2001 May 02; 96(5):1409-16. PubMed ID: 11374675
    [Abstract] [Full Text] [Related]

  • 10. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence.
    Parente F, Bargiggia S, Bollani S, Colombo E, Bianchi Porro G.
    Hepatogastroenterology; 1998 May 02; 45(22):990-3. PubMed ID: 9755995
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled evaluation of one year therapy with sucralfate in healed duodenal ulcer.
    Moshal MG, Spitaels JM, Manion GL.
    Scand J Gastroenterol Suppl; 1983 May 02; 83():57-9. PubMed ID: 6356322
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
    Lazzaroni M, Perego M, Bargiggia S, Maconi G, Fiocca R, Solcia E, Franceschi M, Cesana B, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1997 Jun 02; 29(3):220-7. PubMed ID: 9646213
    [Abstract] [Full Text] [Related]

  • 14. Long-term treatment of duodenal ulcer with pirenzepine. A double-blind, placebo-controlled trial.
    Dal Monte PR, Bianchi Porro G, Petrillo M, Giuliani-Piccari G, D'Imperio N, Daniotti S.
    Scand J Gastroenterol Suppl; 1982 Jun 02; 72():225-8. PubMed ID: 6753116
    [Abstract] [Full Text] [Related]

  • 15. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A, Dattilo M.
    Ital J Gastroenterol Hepatol; 1997 Aug 02; 29(4):312-9. PubMed ID: 9476183
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G, Lazzaroni M, Bargiggia S, Maconi G, Trespi E, Perego M, Alvisi C, Villani L, Luinetti O, Fiocca R, Franceschi M, Cesana B, Solcia E.
    Am J Gastroenterol; 1996 Apr 02; 91(4):695-700. PubMed ID: 8677931
    [Abstract] [Full Text] [Related]

  • 18. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
    Fallone CA, Loo V, Joseph L, Barkun J, Kostyk R, Barkun AN.
    Clin Invest Med; 1999 Oct 02; 22(5):185-94. PubMed ID: 10579057
    [Abstract] [Full Text] [Related]

  • 19. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 02; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 20. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr 02; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.